Linc (LINC): Company Update
Company Update Transcript of Earnings Call held on 27th May, 2026 Transcript of Earnings Call held on 27th May, 2026
Read articleAI-assisted articles on quarterly results, exchange filings, and earnings calls — tied to the companies you follow.
20 articles published
Results for “LINC” — Clear filters
Company Update Transcript of Earnings Call held on 27th May, 2026 Transcript of Earnings Call held on 27th May, 2026
Read articleCompany Update Transcript of Earnings Call held on 27th May, 2026 Transcript of Earnings Call held on 27th May, 2026
Read articleAnalysts/Institutional Investor Meet/Con. Call Updates Linc Limited has informed the Exchange about Transcript Linc Limited has informed the Exchange about Transcript
Read articleAnalysts/Institutional Investor Meet/Con. Call Updates Linc Limited has informed the Exchange about Transcript Linc Limited has informed the Exchange about Transcript
Read articleLinc (LINC) saw unusual trading activity with 115.92K shares traded at ₹99.71. This signal may indicate a potential breakout or news impact.
Read articleLincoln Pharmaceuticals has recommended a final dividend of Rs 1.80 per equity share for the financial year, following its board meeting on May 28, 2026. The announcement was made through NSE corporate filings.
Read articleLincoln Pharmaceuticals Board has recommended a final dividend of Rs 1.80 per equity share for FY26, following its May 28, 2026 meeting. The proposal awaits shareholder approval.
Read articleLincoln Pharmaceuticals Board recommends final dividend of Rs 1.80 per equity share following May 28, 2026 board meeting for shareholder approval.
Read articleLincoln Pharmaceuticals Limited's board has recommended a final dividend of Rs 1.80 per equity share following its meeting on May 28, 2026.
Read articleLinc (LINC) declined 0.50% to ₹99.71 with volume reaching 115.92K shares, suggesting heightened market attention on the stock.
Read articleLincoln Pharmaceuticals has recommended a final dividend of Rs 1.80 per equity share following its May 28, 2026 board meeting, subject to shareholder clearance.
Read articleLincoln Pharmaceuticals has recommended a final dividend of Rs 1.80 per equity share (18%) for FY2026, subject to approval at the upcoming Annual General Meeting.
Read articleLincoln Pharmaceuticals has recommended a final dividend of Rs 1.80 per equity share for FY26, representing an 18% return on the Rs 10 face value.
Read articleNSE & BSE filings, quarterly results, insider trades, and smart volume alerts — delivered on WhatsApp or Telegram. No separate app to install.
"ZTOX alerts helped me catch a multi-bagger stock last quarter. The insider deals notifications are absolutely game-changing for retail investors."
No credit card required. Connect WhatsApp or Telegram in minutes.